Dr. Gabriele Bergers, Professor in the Department of Neurological Surgery, is a PI in the Brain Tumor Research Center (BTRC) and holds the Neill. H. and Linda S. Brownstein Chair in Brain Tumor Research at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco. She is an internationally recognized scientist in the field of tumor angiogenesis and mouse models of carcinogenesis. Her laboratory has made seminal discoveries regarding both the interactions among tumor cells, the vasculature, and inflammatory cell constituents in regulating neovascularization and invasion in various mouse models of brain and pancreatic cancer and in revealing and understanding intrinsic and evasive resistance mechanisms of tumors during the course of antiangiogenic therapy. Prof. Bergers’ laboratory has made seminal discoveries elucidating the interactions among tumor cells and the blood vessels and inflammatory cells of the vascular niche in regulating neovascularization and invasion in various mouse models of brain and pancreatic cancer, and in revealing and understanding intrinsic and evasive resistance mechanisms of tumors during Prof. Bergers has received numerous awards for her research, including the prestigious Sidney Kimmel and Sandler Opportunity Award, and has been an External Advisory Board member for various universities and pharmaceutical companies, including Amgen and Pfizer, and is currently on the Editorial Board of Cancer Research and Science. She has been serving on the NIH Tumor Microenvironment Study Section since 2006 and was Chair from 2010-12. In addition, Dr. Bergers is the co-director of the TMEN (Tumor Microenvironment) Brain Tumor Center at UCSF , a member of the NIH TMEN workgroup, as well as an EAB member at the Max-Planck-Institute for Biomedicine (Vascular Biology focus) in Muenster, Germany. She is also a member of the Rosalind Franklin Society.
« Go Back